EFFECT ·Filed Mar 16, 2026
IPO/offering going effective
Actionable Insight • Neutral
Traders should monitor for imminent pricing and share allocation details, which may precede an IPO or follow-on offering. The effectiveness creates potential for near-term share issuance and volatility.
Final — all horizons settled through T+60d ⚠ clustered
NSRX ▼ -6.13% at T+60d
NEUTRAL call -6.13% · α vs SPY -16.61% · entry $3.10 → $2.91
T+1d
-10.00%
call -10.00% · α -10.27%
$2.79
settled 7mo ago
T+5d
-19.35%
call -19.35% · α -17.31%
$2.50
settled 7mo ago
T+20d
-27.42%
call -27.42% · α -31.20%
$2.25
settled 7mo ago
T+60d
-6.13%
call -6.13% · α -16.61%
$2.91
settled 5mo ago
Price Chart
Loading chart...
Executive Summary
Nasus Pharma Ltd's Form F-1 registration statement has become effective, allowing the company to proceed with its planned equity offering. This is likely an IPO or follow-on offering, enabling the company to issue shares to the public starting March 13, 2026.
Key Facts
- Form F-1 has become effective as of March 13, 2026, permitting Nasus Pharma Ltd to issue securities.
- The filing is a standard EFFECT notice, indicating the SEC has approved the registration of an offering.
- No specific offering size, price, or share count is disclosed in the available documents.
- The company is based in Tel Aviv and operates in the pharmaceutical preparations sector (SIC 2834).
Financial Impact
Not specified
dilutionequitymarket_cap
Risk Factors
- Potential for share dilution if a follow-on offering is executed.
- Uncertainty around offering size and timing may create market volatility once details are released.
Market Snapshot
Exchange
NYSE
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-000817 |
| Document: 9999999995-26-000817-index.html | 9999999995-26-000817 |
| Document: 9999999995-26-000817.txt | 9999999995-26-000817 |
16 reports for NSRX
40% Hit rate @ T+20 Went positive at some point 3 of 5 best @ T+20▲ +53.26%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 8, 2026 18d ago | 6-K | $3.51 | awaiting T+20 | — | $3.49 (−0.57%) |
Sep 23, 2026 4w ago | 3 | $3.64 $3.06 | ▼ −15.93% | ▼ −16.62% | $3.49 (−4.12%) |
Sep 18, 2026 5w ago | 424B5 | $3.44 $3.21 | ▲ +6.83% | ▲ +5.92% | $3.49 (−1.45%) |
Sep 14, 2026 6w ago | 6-K | $3.65 $3.32 | ▼ −9.04% | ▼ −11.30% | $3.49 (−4.38%) |
Sep 14, 2026 6w ago | EFFECT | $3.65 $3.32 | ▼ −9.04% | ▼ −11.30% | $3.49 (−4.38%) |
Aug 21, 2026 9w ago | EFFECT | $4.00 $3.44 | ▼ −14.00% | ▼ −13.47% | $3.49 (−12.75%) |
Aug 19, 2026 9w ago | 6-K | $3.84 $3.53 | ▼ −8.07% | ▼ −6.12% | $3.49 (−9.11%) |
Aug 17, 2026 10w ago | 6-K | $3.70 $3.59 | ▼ −2.97% | ▼ −1.00% | $3.49 (−5.68%) |
Aug 17, 2026 10w ago | Press Release | $3.70 $3.59 | ▼ −2.97% | ▼ −1.00% | $3.49 (−5.68%) |
Apr 1, 2026 29w ago | EFFECT | $2.55 $2.56 | ▼ −0.39% | ▲ +9.33% | $3.49 (−36.86%) |
Showing 10 of 16
US Market Status
Market Closed — Opens Tue (16h 41m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers